openPR Logo
Press release

Global Bronchitis Treatment Market Size, Share, Trends and Forecast To 2020-2026

06-29-2020 10:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The global bronchitis treatment market is projected to exhibit a significant growth, at a CAGR of around 3.4%, during the forecast period. The increasing number of smokers across the globe is increasing the prevalence of pulmonary disease. According to the World Health Organization (WHO), smoking is the one of the leading cause of mortalities across the globe, estimating to around seven million fatalities across the globe every year. Smoke caused by tobacco produces tar in the lungs, which ultimately results in coughs, wheezing, colds, lung cancer, and asthma. As per WHO, around 235 million people have asthma across the globe. High prevalence of asthma will result in investment toward the diseases by the government and patients for diagnosis and treatment of bronchitis.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/bronchitis-treatment-market

Furthermore, air pollution is also increasing globally which is another major factor leading to the growth of asthma patients. Significant rise in the level of air pollution is one of the major causes of lung diseases. As per WHO, around nine out of 10 people across the globe breathe polluted air and seven million mortalities occurred every year due to exposure to fine particles present in polluted air. The exposure to certain fine particles presents in air is the prime factor for air pollution that extremely affects lungs, leading to the development of bronchitis. According to WHO, over 90% of mortalities related to air pollution occurs in low and middle-income nations of the Asia and Africa. It has been followed by the Eastern-Mediterranean region, including the Latin America and Europe.

A Full Report of Global Bronchitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/bronchitis-treatment-market

As per WHO, around 43% of all lung disease and lung cancer mortalities occur due to air pollution. It causes around 1.8 million mortalities annually. Around 25% of all mortalities attribute to air pollution, which estimated for around 2.4 million mortalities. Moreover, there are nearly 40% of global population, accounting for nearly 3 billion people who do not have access to clean cooking fuel and technologies at their homes. It is further considered as another main source of household air pollution. It represents that the rising air pollution concern is the major cause of lung diseases such as acute bronchitis, and asthma, which in turn is contributing to the growth of the bronchitis treatment market.

Nitrogen dioxide is considered as a deep lung irritant and is widely regulated by the US Environmental Protection Agency (EPA). The standard made by the EPA includes a minimal use of nitrogen oxide; not more than 188 micrograms/m3 for one-hour average or not more than 100 micrograms/m3 as an annual average. The burning of fossil fuels in industries, such as automobiles and power plants, leads to the formation of mixture of certain gases, which includes nitrogen dioxide and nitric oxide, and these are considered pollutants that affect the human health, including respiratory system. Therefore, there are several studies in place that have consistently found a significant prevalence of symptoms of chronic bronchitis in areas with higher level of air pollution. This, in turn, is leading to the growth of the global bronchitis treatment market.

Global Bronchitis treatment Market-Segmentation

By Technology

Medication

o Antibiotics

o Anti-inflammatory drugs

o Bronchodilators

o Others (Mucolytics)

Oxygen Therapy

Global Bronchitis treatment Market– Segment by Region

North America

United States
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Company Profiles

Aurobindo Pharma Ltd.
Bayer AG
Boehringer Ingelheim International GmbH

Cipla Ltd.
Dr Reddy's Laboratories Ltd.
GlaxoSmithKline PLC
Lupin Pharmaceuticals, Inc.

Mayne Pharma Group Ltd.
Merck & Co., Inc.
Mucinex (Reckitt Benckiser Group plc)
Novartis AG
Pfizer Inc.
Sanofi SA
Teva Pharmaceutical Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/bronchitis-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bronchitis Treatment Market Size, Share, Trends and Forecast To 2020-2026 here

News-ID: 2081755 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the